Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dietary macromolecules in the gastrointestinal lumen and the intestinal glycocalyx constitute the primary interface for nutrient processing and absorption in the human body. This complex environment includes ingested proteins, lipids, and carbohydrates, as well as the glycocalyx—a dense, carbohydrate-rich layer of glycoproteins and glycolipids on the apical surface of intestinal epithelial cells (Source: NIH/NCBI - PMC4951383). The glycocalyx acts as a physical barrier and a scaffold for essential brush border enzymes, such as sucrase-isomaltase and peptidases, which facilitate the final stages of digestion before transport into the bloodstream (Source: StatPearls - NBK544242). Pathological alterations in this environment are linked to conditions like malabsorption, obesity, and inflammatory bowel disease. Therapeutic strategies often involve modulating the activity of enzymes within this space, such as using alpha-glucosidase inhibitors like acarbose for diabetes or lipase inhibitors like orlistat for weight management (Source: PubChem - Compound 444290, 3034034). Additionally, luminal binders like sevelamer are used to sequester ions such as phosphate directly within the gastrointestinal tract to manage systemic metabolic imbalances.
Inhibition of luminal enzymes (e.g., lipases, alpha-glucosidases), physical sequestration of nutrients or ions, osmotic modulation of luminal fluid, and enzymatic replacement of deficient digestive factors.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary macromolecules in gastrointestinal lumen and intestinal glycocalyx.